Moderna (MRNA) Tops Q4 EPS by $1.39, Announces $3 billion share repurchase plan
Get Alerts MRNA Hot Sheet
Join SI Premium – FREE
Moderna (NASDAQ: MRNA) reported Q4 EPS of $11.29, $1.39 better than the analyst estimate of $9.90. Revenue for the quarter came in at $7.2 billion versus the consensus estimate of $6.78 billion.
- Moderna announces a new $3 billion share repurchase plan
For earnings history and earnings-related data on Moderna (MRNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kinder Morgan (KMI) Misses Q1 EPS by 1c
- Liberty Oilfield Services (LBRT) Misses Q1 EPS by 6c, provides outlook
- Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
Create E-mail Alert Related Categories
Earnings, Stock BuybacksRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!